Breast lumps

Revision as of 13:20, 22 April 2013 by Kalsang Dolma (talk | contribs)
Jump to navigation Jump to search
Breast lumps
File:Breast lump.jpg
A small, palpable, hard lump in breast carcinoma.
Image courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology

Breast lumps Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Breast lumps from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Breast lumps On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Breast lumps

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Breast lumps

on Breast lumps

Breast lumps in the news

Blogs on Breast lumps

Directions to Hospitals Treating Breast lumps

Risk calculators and risk factors for Breast lumps

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


Epidemiology and Demographics

  • 40% of breast complaints leading to an office visit
  • 6% of all women ages 40-69 seek advice about breast lumps
  • Cysts and fibroadenomas = most common underlying conditions
  • 75-80% of breast biposies in the US are for benign lesions
  • Breast cancer detected in
    • 4% of women with breast complaints
    • 8% of women with abnormal screening mammograms
    • 2% of women with abnormal findings on screening clinical breast exam

Breast Cancer Risk Factors

Breast Cancer Risk Factors

Age (> 70 vs. < 35) RR 17.0
Positive Family History RR 2.6
Early Menarche (< 12 years old) RR 1.5
Late Menopause (> 55 years old) RR 2.0
HRT Use (current) RR 1.2-1.4
OCP Use (ever) RR 1.07-1.2
Postmenopausal Body Mass Index (> 30.7) RR 1.6

Pathophysiology & Etiology

  • Cysts
    • Common in premenopausal women > 40 years old
    • Less frequent in younger women (10% of breast masses in women < 40 years old)
    • Uncommon in postmenopausal women not on hormone replacement therapy (HRT)
    • Often fluctuate with menstrual cycle
    • Especially common during periods of hormonal irregularity
  • Fibroadenomas
  • Prominent Fibrocystic Change (without a dominant mass)
  • Fat Necrosis
  • Malignancy

Diagnosis

  • Triple Diagnosis
    • Use of physical examination, mammogram and fine needle aspiration biopsy (FNAB) for diagnosis of palpable lumps
      • If all 3 are benign: < 1% incidence of breast cancer
        • Follow patient with complete breast exam (CBE) every 3-6 months x 1 year to ensure stability
      • If all 3 are positive: 99.4% incidence breast cancer
      • If any 1 is positive: excisional biopsy recommended

Differential Diagnosis of a Breast Lump

History and Symptoms

  • Characteristics of lump:
    • Location and duration of its presence, changes in size
    • Associated nipple discharge
    • Changes with menstrual cycle
      • Cysts tend to be more prominent
    • Premenstrually and may regress during follicular phase
    • Tenderness
      • Rapidly developing cysts may be tender
  • Prior history of breast cancer or breast biopsy (atypical hyperplasia on prior biopsy most worrisome)

Physical Examination

  • Suspicious findings
    • Single lesion
    • Hard
    • Immobile
    • Irregular borders
    • Size > 2 cm
  • Exam not reliable for distinguishing benign vs. malignant (PPV 73%, NPV 87% at referral center)
  • Cancers may be tender on exam (~ 15% of cases)
  • Exam should include evaluation for supraclavicular and axillary LAN

Echocardiography or Ultrasound

  • Ultrasonography:
    • In women < 35
    • May be helpful in conjunction with mammogram for women 35 and over
    • Also for evaluation of nonpalpable mass detected on screening mammogram
    • Simple cyst on ultrasound has extremely low risk cancer

Other Imaging Findings

Mammography

  • Any woman age 35 or over with a breast mass
  • Suspicious findings
    • Increased density
    • Irregular margins
    • Spiculation
    • Clustered
  • Microcalcifications
  • Can miss 10-20% of clinically palpable breast cancers
  • Not cost-effective or clinically helpful in patients < 35 unless high suspicion cancer

Other Diagnostic Studies

Fine Needle Aspiration/Biopsy

  • Fine Needle Aspiration
    • Office procedure for evaluation of palpable cyst (22-24 gauge needle)
    • Bloody fluid
      • Send for cytology and refer for surgical biopsy
    • Non-bloody fluid
      • Cytology extremely low yield (do not send)
      • If mass disappears, reexamine pt in 4-6 weeks
      • If no recurrence, resume routine follow-up
      • If recurrence, can repeat aspiration
      • Consider biopsy if further recurrence
    • Non-bloody fluid but residual mass after aspiration: surgical biopsy
    • Solid mass (no fluid)
      • Surgical biopsy or fine needle aspiration biopsy
  • Fine Needle Aspiration Biopsy (FNAB)
    • Aspiration of cells from a solid mass
    • 21 gauge needle, operator-dependent
    • Wide variation in sens (65-98%), spec (34-100%)
  • Core Needle Biopsy
    • 14-18 gauge needle allows for better histologic sample
    • Used mostly for evaluation of non-palpable masses (mammogram or ultrasound guidance)
    • Compares favorably with surgical biopsy at lower cost
  • Excisional Biopsy
    • Recommended if solid mass suspicious for cancer by exam or mammo
    • Also recommended for palpable mass not seen on mammogram or for abnormal biopsy

Treatment

Recommendations

  • Women < age 35
    • If no distinct lump found or primary care physician (PCP) unsure: refer to breast specialist for 2nd opinion
    • If non-suspicious lump on exam
      • Reassess 3-10 days after onset of next menses
      • If lump regresses, no further evaluation needed
    • If lump remains palpable and feels cystic
      • Fine needle aspiration (FNA)
      • Management of bloody vs. non-bloody fluid as above
    • If lump does not feel cystic
      • Ultrasound
      • If solid mass: FNAB, core biopsy or excisional biopsy
      • If cyst, FNA as above
      • If non-suspicious solid mass < 1 cm: likely fibroadenoma
      • Can follow by physical examination every 3-6 months
    • Mammography generally not helpful in this age group
  • Women age 35 and over
    • Mammography and ultrasonography (note: mammography has 10-20% false-negative rate)
    • Cystic mass
      • FNA with mgmt of bloody vs. non-bloody fluid as above
    • Solid mass
      • Core biopsy, FNAB or excisional biopsy if no suspicious features
      • Excisional biopsy recommended if mass is suspicious by exam or mammogram
    • No specific findings on mammogram and ultrasound: refer to surgeon for likely excision

Acknowledgements

The content on this page was first contributed by: Rebecca Cunningham, M.D.

List of contributors:


Suggested Reading and Key General References

Suggested Links and Web Resources

For Patients

Template:WikiDoc Sources